NEJM: Results From Targeted Therapy for Ulcerative Colitis Study
Cedars-SinaiAn international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.